Hospital
Bartow Regional Medical Center, INC.
Bartow Regional Medical Center, INC. was paid $9.00M by Medicaid between Jan 2018 and Dec 2024, across 142 billing codes. Its largest line is 99283, emergency room visit (moderate) — 36% of everything it billed.
33Billing provider infoBARTOW REGIONAL MEDICAL CENTER, INC.
BARTOW, FL 33830
BARTOW, FL 33830
33aNPI1558734095assigned 11/05/2015
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.00M
24GClaims311,323
24DCodes billed142
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#57 of 163
Median peer was paid$4.77M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,942 | $160K | |
| 2019 | 58,783 | $1.02M | |
| 2020 | 46,104 | $801K | |
| 2021 | 58,801 | $1.43M | |
| 2022 | 58,360 | $2.15M | |
| 2023 | 48,843 | $2.13M | |
| 2024incomplete | 25,490 | $1.30M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 36,140 | 33,023 | $3.23M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 22,719 | 20,185 | $1.60M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.2% | 8,456 | 7,862 | $737K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.5% | 6,135 | 5,298 | $497K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.1% | 2,518 | 2,348 | $459K |
| 80053 | Comprehensive metabolic panel | 3.7% | 15,730 | 13,861 | $336K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2.7% | 386 | 367 | $246K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.7% | 2,262 | 1,921 | $241K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.3% | 1,689 | 1,474 | $205K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.1% | 3,130 | 2,837 | $190K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.6% | 4,777 | 3,842 | $141K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 7,900 | 7,547 | $95K |
130 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,502 | $81K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 68 | $74K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,790 | $74K |
| 81025 | <1% | 8,249 | $67K | |
| 87631 | <1% | 1,089 | $62K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,864 | $58K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 713 | $46K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 587 | $45K |
| 82948 | <1% | 4,477 | $44K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,895 | $36K |
| 36415 | Collection of venous blood by venipuncture | <1% | 17,657 | $32K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 7,188 | $27K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,037 | $26K |
| 81003 | <1% | 18,971 | $26K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,281 | $25K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,478 | $24K |
| 73630 | <1% | 1,097 | $23K | |
| 71045 | Radiologic examination, chest; single view | <1% | 8,961 | $21K |
| G0378 | Hospital observation service, per hour | <1% | 2,460 | $21K |
| 73130 | <1% | 705 | $20K | |
| 73610 | <1% | 762 | $18K | |
| 73562 | <1% | 906 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,554 | $13K |
| 84702 | <1% | 1,223 | $12K | |
| 74018 | <1% | 884 | $9K | |
| 73030 | <1% | 641 | $9K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 168 | $8K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 441 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,358 | $8K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 607 | $7K |
| 72100 | <1% | 598 | $6K | |
| 84484 | <1% | 5,562 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20,504 | $6K |
| 73110 | <1% | 242 | $5K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 221 | $5K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 126 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,875 | $4K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 84 | $4K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 15 | $3K |
| 87070 | <1% | 75 | $3K | |
| 73140 | <1% | 41 | $2K | |
| 97597 | <1% | 79 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 96 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,703 | $2K |
| 72131 | <1% | 13 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,948 | $2K |
| 86900 | <1% | 707 | $2K | |
| 85380 | <1% | 442 | $1K | |
| 83880 | <1% | 1,307 | $1K | |
| 85610 | <1% | 2,223 | $1K | |
| 85730 | <1% | 1,559 | $1K | |
| 73590 | <1% | 38 | $1K | |
| 72040 | <1% | 123 | $1K | |
| 29125 | <1% | 142 | $955.14 | |
| 87186 | <1% | 1,165 | $953.50 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,363 | $944.67 |
| 82805 | <1% | 30 | $856.16 | |
| 76801 | <1% | 275 | $826.06 | |
| 73080 | <1% | 45 | $763.18 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,677 | $712.62 |
| 71101 | <1% | 14 | $673.57 | |
| 87077 | <1% | 1,473 | $631.96 | |
| 74019 | <1% | 148 | $606.68 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,189 | $605.38 |
| 83735 | <1% | 1,280 | $601.54 | |
| 10060 | <1% | 15 | $566.79 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 455 | $562.84 |
| 76830 | Ultrasound, transvaginal | <1% | 119 | $561.55 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,332 | $545.39 |
| 87040 | <1% | 682 | $533.53 | |
| 87400 | <1% | 173 | $521.40 | |
| 12001 | <1% | 65 | $509.90 | |
| 82077 | <1% | 115 | $446.77 | |
| 85027 | <1% | 586 | $437.48 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 25 | $435.05 |
| 80061 | Lipid panel | <1% | 25 | $435.05 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 39 | $435.05 |
| 87480 | <1% | 712 | $403.90 | |
| 83690 | <1% | 5,751 | $403.12 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 148 | $396.98 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,708 | $385.09 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,444 | $354.20 |
| 12011 | <1% | 27 | $316.80 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 18 | $292.30 |
| 74022 | <1% | 196 | $288.01 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,053 | $259.95 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,610 | $210.16 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,349 | $197.71 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,894 | $196.02 |
| 0240U | <1% | 90 | $155.88 | |
| 94760 | <1% | 551 | $151.69 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,560 | $134.90 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 720 | $103.69 |
| 87510 | <1% | 697 | $97.98 | |
| 84145 | <1% | 125 | $95.24 | |
| 83605 | <1% | 243 | $95.24 | |
| 87660 | <1% | 697 | $90.96 | |
| 93971 | <1% | 41 | $74.60 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,327 | $73.89 |
| A9270 | Non-covered item or service | <1% | 101 | $73.53 |
| J1815 | Injection, insulin, per 5 units | <1% | 279 | $73.19 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,315 | $71.89 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $20.48 |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 380 | $14.70 |
| 87430 | <1% | 67 | $7.74 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 434 | $6.83 |
| 86901 | <1% | 703 | $4.40 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 357 | $0.00 |
| 90714 | 0% | 50 | $0.00 | |
| 0353U | 0% | 71 | $0.00 | |
| 90715 | 0% | 31 | $0.00 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 19 | $0.00 |
| 87634 | 0% | 13 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 71 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 0% | 329 | $0.00 |
| 84703 | 0% | 617 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 44 | $0.00 |
| 87205 | 0% | 83 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 73 | $0.00 |
| 00126 | 0% | 276 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 85 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 208 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 13 | $0.00 |
| 73090 | 0% | 26 | $0.00 | |
| 86140 | 0% | 18 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 26 | $0.00 |
| 0352U | 0% | 44 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 119 | $0.00 |
| J3410 | Injection, hydroxyzine hcl, up to 25 mg | 0% | 15 | $0.00 |
| 82150 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWATERS, GLENN (EVP)
| Provider | Location | Paid |
|---|---|---|
| ST. Anthonys Hospital, INC. | Saint Petersburg, FL | $8.94M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.